GMFB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.304800E-01
Normal-vs-Stage2
6.984400E-01
Normal-vs-Stage3
5.556500E-02
Normal-vs-Stage4
7.331800E-01
Stage1-vs-Stage2
6.672000E-01
Stage1-vs-Stage3
1.881830E-01
Stage1-vs-Stage4
3.080200E-01
Stage2-vs-Stage3
1.565820E-01
Stage2-vs-Stage4
2.793200E-01
Stage3-vs-Stage4
1.676550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.437400E-01
Normal-vs-AfricanAmerican
9.713400E-01
Normal-vs-Asian
1.704010E-01
Caucasian-vs-AfricanAmerican
6.015000E-01
Caucasian-vs-Asian
9.992300E-02
AfricanAmerican-vs-Asian
1.769830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.383200E-01
Normal-vs-Female
7.678400E-01
Male-vs-Female
8.945400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.850600E-01
Normal-vs-Age(41-60Yrs)
8.258600E-01
Normal-vs-Age(61-80Yrs)
5.649400E-01
Normal-vs-Age(81-100Yrs)
2.581800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.580800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.620400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.794400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.818200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.683670E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.402600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.927400E-01
Normal-vs-Daily Drinker
2.807800E-01
Normal-vs-Weekly Drinker
4.327000E-01
Normal-vs-Occasional Drinker
6.725200E-01
Normal-vs-Social Drinker
8.976600E-01
Non Drinker-vs-Daily Drinker
6.788200E-01
Non Drinker-vs-Weekly Drinker
9.729400E-01
Non Drinker-vs-Occasional Drinker
2.329600E-02
Non Drinker-vs-Social Drinker
3.542600E-01
Daily Drinker-vs-Weekly Drinker
7.885000E-01
Daily Drinker-vs-Occasional Drinker
1.207510E-02
Daily Drinker-vs-Social Drinker
2.669800E-01
Weekly Drinker-vs-Occasional Drinker
6.016200E-02
Weekly Drinker-vs-Social Drinker
4.144600E-01
Occasional Drinker-vs-Social Drinker
3.600400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.807400E-01
Normal-vs-Grade 2
7.473800E-01
Normal-vs-Grade 3
7.496400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.201200E-01
Grade 1-vs-Grade 3
9.076800E-01
Grade 1-vs-Grade 4
4.807400E-01
Grade 2-vs-Grade 3
9.710400E-01
Grade 2-vs-Grade 4
7.473800E-01
Grade 3-vs-Grade 4
7.496400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.022800E-01
Normal-vs-NonDiabetic
7.098800E-01
Diabetic-vs-NonDiabetic
2.325400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.804200E-02
Normal-vs-NoPancreatitis
7.527400E-01
Pancreatitis-vs-NoPancreatitis
1.504220E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.202000E-01
Normal-vs-N1
7.249000E-01
N0-vs-N1
8.120400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.782800E-01
Normal-vs-TP53-NonMutant
7.307000E-01
TP53-Mutant-vs-TP53-NonMutant
3.038800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
